510(k) Report

510(k) · Cleared

Cleared

Nidek Multi Color Laser Photocoagulator, Model MC-7000

K974732510(k) TraditionalCleared Mar 18, 199890-day reviewClass II21 CFR 878.4810

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Nidek, Inc. · GEX Powered Laser Surgical Instrument

Cleared on Mar 18, 1998 as substantially equivalent to K932468 (Coherent Medical Group, 1993) and 1 other predicate after a 90-day review. Its family tree reaches back 1 generation to 1993.

Decided
Mar 18, 1998
Review
90 days
Class
Class II
Product code
GEX
Recalls
None
Predicates
2

Its longest line of descent runs back 1 generation to K930543 (1993). 2 ancestors in all. No later device cites it as a predicate yet.

Other ancestors, by year cleared 1993: 1 other ancestorK930543 · E-25 Krypton Ion Laser (Surgica K5) · Hgm, Inc. · 1993199019921994199619982000
Other ancestors, by generation 1 generation back: 1 other ancestor K930543 · E-25 Krypton Ion Laser (Surgica K5) · Hgm, Inc. · 19930
  1. Root · 1 generation backK930543 E-25 Krypton Ion Laser (Surgica K5)Hgm, Inc. · 1993
  2. This deviceK974732 Nidek Multi Color Laser Photocoagulator, Model MC-7000Nidek, Inc. · 1998
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K930543E-25 Krypton Ion Laser (Surgica K5)Hgm, Inc.1993—
0 (this device)K974732Nidek Multi Color Laser Photocoagulator, Model MC-7000Nidek, Inc.1998—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199310
FIG. 1 — Lineage of K974732, 1993–1998Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GEX? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new GEX device

  1. #1 K222064 The Alma Soprano Titaniumscore 38.1 · 24 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K932468Novus Multiwavelength
Summary page 1
…espondent: Ken Kato, VP Phone: 510-226-5700 Fax: 510-226-5750 2. Device Name Nidek MC-7000 Photo coagulator 3. Predicate Devices Coherent Novus Omni made by Coherent (K932468) HGM Spectrum K5 made by HGM (K930543) 4. Intended Use Laser beam generated by MC-7000 is to be used for photocoagulation in oph…
Coherent Medical Group1993—
*K930543E-25 Krypton Ion Laser (Surgica K5)
Summary page 1
…6-5700 Fax: 510-226-5750 2. Device Name Nidek MC-7000 Photo coagulator 3. Predicate Devices Coherent Novus Omni made by Coherent (K932468) HGM Spectrum K5 made by HGM (K930543) 4. Intended Use Laser beam generated by MC-7000 is to be used for photocoagulation in ophthalmic indications in transpupillary…
Hgm, Inc.1993—

Also cleared against K932468: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • None of the 2 ancestors has a recall.
  • 1 other device also cites its predicate K932468.

How does its category compare?

All GEX devices

GEX Powered Laser Surgical Instrument: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · GEX

83in 2025

2007: 732008: 1072009: 692010: 502011: 412012: 452013: 462014: 612015: 472016: 512017: 672018: 512019: 412020: 522021: 532022: 602023: 522024: 822025: 832026 (partial year): 57
2007high 107 (2008) · low 41 (2011)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GEX

90in 2025

2007: 79 days median2008: 86 days median2009: 100 days median2010: 96 days median2011: 83 days median2012: 118 days median2013: 144 days median2014: 147 days median2015: 112 days median2016: 114 days median2017: 90 days median2018: 78 days median2019: 88 days median2020: 90 days median2021: 123 days median2022: 152 days median2023: 87 days median2024: 90 days median2025: 90 days median2026 (partial year): 90 days median
2007high 152 (2022) · low 78 (2018)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · GEX

3in 2024

2007: 92008: 22010: 42011: 182012: 52013: 32014: 62016: 12017: 5, 1 Class I2018: 52019: 62020: 12023: 62024: 32026 (partial year): 2
2007high 18 (2011) · low 0 (2009)2026

Class I (1 since 2007) Class II/III not classified

Adverse event reports per year · GEX

2,720in 2025

2007: 3422008: 2322009: 2092010: 1,7112011: 3,0242012: 2,0002013: 2,2362014: 2,0362015: 2,0992016: 2,5852017: 2,9772018: 3,5252019: 2,7092020: 2,1832021: 3,4652022: 2,2882023: 2,3372024: 2,1872025: 2,720
2007high 3,525 (2018) · low 209 (2009)2025

MAUDE reports naming product code GEX, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200773799342
2008107862232
2009691000209
2010509641,711
20114183183,024
20124511852,000
20134614432,236
20146114762,036
20154711202,099
20165111412,585
201767905 (1)2,977
2018517853,525
2019418862,709
2020529012,183
20215312303,465
20226015202,288
2023528762,337
2024829032,187
2025839002,720
202657902—

What is it indicated for?

Delivery of Laser therapeutic radiation is accomplished by two basic means: Transpupillary: 1) Via an optical system attached to a viewing microscope either a slit-lamp or operating microscope. Retinal therapy is further aided by the use of an auxiliary viewing lenses, typically a fundus laser lens, or a wide field examination lens with a laser anti-reflection coating. Anterior segment therapy is further aided by viewing lenses which can reflect the…

Read the full statement (223 words)

Delivery of Laser therapeutic radiation is accomplished by two basic means:

Transpupillary:

1) Via an optical system attached to a viewing microscope either a slit-lamp or operating microscope.

Retinal therapy is further aided by the use of an auxiliary viewing lenses, typically a fundus laser lens, or a wide field examination lens with a laser anti-reflection coating.

Anterior segment therapy is further aided by viewing lenses which can reflect the treatment beam into the chamber angle, either with or without magnification. The lens is treated on the distal surface with a laser anti-reflection coating.

2) Via an optical system attached to an indirect ophthalmoscope either binocular or monocular, with or without auxiliary viewing lenses. Typically a +20 Diopter examination lens with a laser anti-reflection coating is employed.

Inter Operative methods:

1) Via direct radiation administered from a fiber optic cable handpiece which is inserted through an incision and positioned proximal to a point of treatment within the eye. According to the area to be treated, the fiber handpiece be formed in either a straight or curved manner.

Transpupillary laser therapy is commonly employed for the following indications:

Retinal Photocoagulation, either limited or Pan-Retinal

Macular Photocoagulation

Trabeculoplasty for Open Angle Glaucoma

Iridotomy for Acute Angle Closure Glaucoma

Inter-Operative laser therapy is employed for the following indications:

Retinal Photocoagulation, either limited or Pan-Retinal

Macular Photocoagulation

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K974732: Nidek Multi Color Laser Photocoagulator, Model MC-7000.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K974732

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026